Ocular Itching

Eye care pharmaceutical company Harrow announced the completed transfer of new drug applications for Flarex, Natacyn, Tobradex ST, Verkazia and Zerviate, all of which were acquired in July and will now be launched under the company name.

SAN DIEGO — A comparison of over-the-counter Pataday drops with OTC Claritin tablets at 15 minutes and 24 hours showed that the drops were more effective at relieving ocular itching in patients with allergic conjunctivitis.

The FDA has approved a supplemental new drug application for Dextenza, adding ocular itching associated with allergic conjunctivitis to the drug’s current indications, according to a press release from Ocular Therapeutix.

Demodex folliculorum and Demodex brevis are ectoparasites of phylum Arthropoda that inhabit the skin of humans.

Bausch + Lomb’s Alaway, an over-the-counter eye drop, is set to launch in the U.S., the company announced in a press release.

The FDA has accepted a supplemental new drug application for Dextenza for the treatment of ocular itching associated with allergic conjunctivitis, according to a press release from Ocular Therapeutix.

Dextenza demonstrated a statistically significant mean change in ocular itching scores from baseline in patients with allergic conjunctivitis, according to a press release from Ocular Therapeutix.

ATLANTA – Eyevance announced the U.S. launch of Zerviate, indicated for treating ocular itching associated with allergic conjunctivitis.

The first patient has been enrolled in a phase 3 trial of Aldeyra Therapeutics’ allergic conjunctivitis treatment candidate reproxalap, according to a press release.